Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.

<h4>Background and aims</h4>Although the advent of ultra-deep sequencing technology allows for the analysis of heretofore-undetectable minor viral mutants, a limited amount of information is currently available regarding the clinical implications of hepatitis B virus (HBV) genomic hetero...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Norihiro Nishijima, Hiroyuki Marusawa, Yoshihide Ueda, Ken Takahashi, Akihiro Nasu, Yukio Osaki, Tadayuki Kou, Shujiro Yazumi, Takeshi Fujiwara, Soken Tsuchiya, Kazuharu Shimizu, Shinji Uemoto, Tsutomu Chiba
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/71ce1ca7b57f46bbb987a168b831bae7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:71ce1ca7b57f46bbb987a168b831bae7
record_format dspace
spelling oai:doaj.org-article:71ce1ca7b57f46bbb987a168b831bae72021-11-18T07:22:04ZDynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.1932-620310.1371/journal.pone.0035052https://doaj.org/article/71ce1ca7b57f46bbb987a168b831bae72012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22523569/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background and aims</h4>Although the advent of ultra-deep sequencing technology allows for the analysis of heretofore-undetectable minor viral mutants, a limited amount of information is currently available regarding the clinical implications of hepatitis B virus (HBV) genomic heterogeneity.<h4>Methods</h4>To characterize the HBV genetic heterogeneity in association with anti-viral therapy, we performed ultra-deep sequencing of full-genome HBV in the liver and serum of 19 patients with chronic viral infection, including 14 therapy-naïve and 5 nucleos(t)ide analogue(NA)-treated cases.<h4>Results</h4>Most genomic changes observed in viral variants were single base substitutions and were widely distributed throughout the HBV genome. Four of eight (50%) chronic therapy-naïve HBeAg-negative patients showed a relatively low prevalence of the G1896A pre-core (pre-C) mutant in the liver tissues, suggesting that other mutations were involved in their HBeAg seroconversion. Interestingly, liver tissues in 4 of 5 (80%) of the chronic NA-treated anti-HBe-positive cases had extremely low levels of the G1896A pre-C mutant (0.0%, 0.0%, 0.1%, and 1.1%), suggesting the high sensitivity of the G1896A pre-C mutant to NA. Moreover, various abundances of clones resistant to NA were common in both the liver and serum of treatment-naïve patients, and the proportion of M204VI mutants resistant to lamivudine and entecavir expanded in response to entecavir treatment in the serum of 35.7% (5/14) of patients, suggesting the putative risk of developing drug resistance to NA.<h4>Conclusion</h4>Our findings illustrate the strong advantage of deep sequencing on viral genome as a tool for dissecting the pathophysiology of HBV infection.Norihiro NishijimaHiroyuki MarusawaYoshihide UedaKen TakahashiAkihiro NasuYukio OsakiTadayuki KouShujiro YazumiTakeshi FujiwaraSoken TsuchiyaKazuharu ShimizuShinji UemotoTsutomu ChibaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 4, p e35052 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Norihiro Nishijima
Hiroyuki Marusawa
Yoshihide Ueda
Ken Takahashi
Akihiro Nasu
Yukio Osaki
Tadayuki Kou
Shujiro Yazumi
Takeshi Fujiwara
Soken Tsuchiya
Kazuharu Shimizu
Shinji Uemoto
Tsutomu Chiba
Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.
description <h4>Background and aims</h4>Although the advent of ultra-deep sequencing technology allows for the analysis of heretofore-undetectable minor viral mutants, a limited amount of information is currently available regarding the clinical implications of hepatitis B virus (HBV) genomic heterogeneity.<h4>Methods</h4>To characterize the HBV genetic heterogeneity in association with anti-viral therapy, we performed ultra-deep sequencing of full-genome HBV in the liver and serum of 19 patients with chronic viral infection, including 14 therapy-naïve and 5 nucleos(t)ide analogue(NA)-treated cases.<h4>Results</h4>Most genomic changes observed in viral variants were single base substitutions and were widely distributed throughout the HBV genome. Four of eight (50%) chronic therapy-naïve HBeAg-negative patients showed a relatively low prevalence of the G1896A pre-core (pre-C) mutant in the liver tissues, suggesting that other mutations were involved in their HBeAg seroconversion. Interestingly, liver tissues in 4 of 5 (80%) of the chronic NA-treated anti-HBe-positive cases had extremely low levels of the G1896A pre-C mutant (0.0%, 0.0%, 0.1%, and 1.1%), suggesting the high sensitivity of the G1896A pre-C mutant to NA. Moreover, various abundances of clones resistant to NA were common in both the liver and serum of treatment-naïve patients, and the proportion of M204VI mutants resistant to lamivudine and entecavir expanded in response to entecavir treatment in the serum of 35.7% (5/14) of patients, suggesting the putative risk of developing drug resistance to NA.<h4>Conclusion</h4>Our findings illustrate the strong advantage of deep sequencing on viral genome as a tool for dissecting the pathophysiology of HBV infection.
format article
author Norihiro Nishijima
Hiroyuki Marusawa
Yoshihide Ueda
Ken Takahashi
Akihiro Nasu
Yukio Osaki
Tadayuki Kou
Shujiro Yazumi
Takeshi Fujiwara
Soken Tsuchiya
Kazuharu Shimizu
Shinji Uemoto
Tsutomu Chiba
author_facet Norihiro Nishijima
Hiroyuki Marusawa
Yoshihide Ueda
Ken Takahashi
Akihiro Nasu
Yukio Osaki
Tadayuki Kou
Shujiro Yazumi
Takeshi Fujiwara
Soken Tsuchiya
Kazuharu Shimizu
Shinji Uemoto
Tsutomu Chiba
author_sort Norihiro Nishijima
title Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.
title_short Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.
title_full Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.
title_fullStr Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.
title_full_unstemmed Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.
title_sort dynamics of hepatitis b virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/71ce1ca7b57f46bbb987a168b831bae7
work_keys_str_mv AT norihironishijima dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT hiroyukimarusawa dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT yoshihideueda dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT kentakahashi dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT akihironasu dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT yukioosaki dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT tadayukikou dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT shujiroyazumi dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT takeshifujiwara dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT sokentsuchiya dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT kazuharushimizu dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT shinjiuemoto dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
AT tsutomuchiba dynamicsofhepatitisbvirusquasispeciesinassociationwithnucleostideanaloguetreatmentdeterminedbyultradeepsequencing
_version_ 1718423539835469824